Inotropic therapy is used in end-stage heart failure to help relieve and control heart failure symptoms so that you are better able to perform your daily activities. These medications are only used when other drugs no longer control heart failure symptoms.
Inotropic therapy, also known as heart pump medication, stimulates an injured or weakened heart to pump harder. The primary purpose of this medication is to increase the force of the heart muscle's contractions. Inotropic therapy may also speed up the heart's rhythm.
Drug therapy to lower blood pressure has been shown to reduce heart failure rates by 40%-60%.
Reducing blockages in the coronary arteries with anti-cholesterol drugs has been shown to reduce heart failure rates by 30%.
Early diagnosis and treatment of heart-valve abnormalities can prevent heart failure caused by chronic volume overload of the heart's left chamber.
Inotropic therapy for heart failure is first administered in the hospital where you can be closely monitored.
Dobutamine and milrinone are intravenous (through the vein) medications administered by an infusion pump to help ensure the dose is accurate. These drugs may be ordered by your doctor to be given continuously or periodically over 6 to 72 hours, one or more times per week.
Even if you feel well, do not discontinue your inotropic therapy medication from your intravenous catheter line or from your infusion pump without consulting your doctor. If you are discharged from the hospital with an inotropic medication, a home health nurse will provide specific directions on how to care for your intravenous site, catheter, and infusion pump.
What Side Effects Could I Experience?
Notify your doctor or nurse right away the first time any of these side effects occur: